Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cystex is a U.S. consumer healthcare brand focused on over-the-counter urinary health products rather than a traditional drug-development biotech company. Its portfolio includes urinary pain relief tablets, UTI bacteria-control/pain-relief products, urinary health maintenance supplements, urinary and vaginal probiotics, cranberry-based products, wellness powders, and at-home UTI test strips. The brand markets products for both acute symptom management and preventive urinary or vaginal wellness, with a strong emphasis on women’s urinary health and recurrent UTI support. Cystex was formerly known as Cystex Plus and appears to operate as a brand/business owned by Clarion Brands following an acquisition in 2014. There is no evidence of a clinical-stage prescription pipeline; the business is commercial-stage and retail-oriented.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cystex.